West Pharmaceutical Services Reports Q3 Net Sales of $804.6 Million, Up 7.7%
I'm PortAI, I can summarize articles.
West Pharmaceutical Services Inc. reported Q3 2025 net sales of $804.6 million, a 7.7% increase year-over-year, with organic growth of 5.0%. The Proprietary Products segment saw net sales of $647.5 million, up 7.7%, while the Contract-Manufactured Products segment recorded $157.1 million, an 8.0% increase. Operating cash flow for the first nine months was $503.7 million, up 8.7%, and free cash flow increased by 53.7% to $293.9 million. The company repurchased 552,593 shares for $134.0 million at an average price of $242.55 per share.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments